2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Poster Session

[P28] Poster Session 28　Lung Cancer/Thoracic Cancer（EGFR TKI）

[P28-6] Real-world evidence of crizotinib for ROS1- tested patients with non-small cell lung cancer in Japan

○Masahiro Morise (Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password